Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

LON/BVC stock hub

LON/BVC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/BVCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

50.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/BVC

In the news

Latest news · LON/BVC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-16.2

P25 -54.2P50 2.1P75 13.7

ROIC3.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/BVC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	UK
Employees	806
Employees Change	-61%
Employees Change Percent	-7.04
Enterprise value	GBX 39.6M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	IL0010849045
Last refreshed	2026-05-10
Market cap	GBX 50.3M
Price	GBX 14.8
Price currency	GBX
Rev Per Employee	113,568.38x
Sector	Healthcare
Sic	3576
Symbol	lon/BVC
Website	https://www.batm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-27.07%
EV Earnings	-2.9x
EV/FCF	-6.03x
EV/Sales	0.43x
FCF yield	-13.04%
P/B ratio	1.06x
P/S ratio	0.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.5%
EBITDA Margin	3.27%
Gross margin	32.52%
Gross Profit	GBX 29.8M
Gross Profit Growth	5.8%
Gross Profit Growth Q	12.12%
Gross Profit Growth3 Y	2.55%
Gross Profit Growth5 Y	0.29%
Net Income	GBX -13.6M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-5.32%
Profit Margin	-14.88%
Profit Per Employee	GBX -16,902
ROA	0.88
Roa5y	1.05
ROCE	2.64
ROE	-16.23
Roe5y	-1.87
ROIC	3.62
Roic5y	2.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.68%
Cagr15y	-2.9%
Cagr1y	2.07%
Cagr20y	-2.46%
Cagr3y	-17.33%
Cagr5y	-30.84%
Div CAGR10	0%
Div CAGR5	0%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	5x
Revenue Growth Q	7.5x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	2x
Revenue Growth5 Y	0.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.94
Assets	GBX 84.6M
Cash	GBX 17.4M
Current Assets	GBX 59.3M
Current Liabilities	GBX 32M
Debt	GBX 7.7M
Debt EBITDA	GBX 1.68
Debt Equity	GBX 0.16
Debt FCF	GBX -1.17
Equity	GBX 47.6M
Interest Coverage	0.99
Liabilities	GBX 36.9M
Long Term Assets	GBX 25.3M
Long Term Liabilities	GBX 4.9M
Net Cash	GBX 9.7M
Net Cash By Market Cap	GBX 19.24
Net Cash Growth	-43.13%
Net Debt EBITDA	GBX -3.23
Net Debt Equity	GBX -0.2
Tangible Book Value	GBX 38.9M
Tangible Book Value Per Share	GBX 0.11
WACC	9.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.85
Inventory Turnover	2.71
Net Working Capital	GBX 17.3M
Quick ratio	1.17
Working Capital	GBX 27.6M
Working Capital Turnover	GBX 2.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%
Dividend per share	GBX 0
Last Dividend	GBX 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-6.63%
1Y total return	2.07%
200-day SMA	15.83
3Y total return	-43.51%
50-day SMA	13.99
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.17%
All Time High	762.5
All Time High Change	-98.06%
All Time High Date	2000-09-04
All Time Low	6.98
All Time Low Change	112.03%
All Time Low Date	2003-03-31
ATR	0.77
Beta	0.73
Beta1y	0.12
Beta2y	0.01
Ch YTD	-8.22
High	14.8
High52	20
High52 Date	2025-12-01
High52ch	-26%
Low	14.15
Low52	12.2
Low52 Date	2026-02-23
Low52ch	21.31%
Ma50ch	5.79%
Price vs 200-day SMA	-6.51%
RSI	59.43
RSI Monthly	40.76
RSI Weekly	48.58
Sharpe ratio	-0x
Sortino ratio	0.12
Total Return	-0.08%
Tr YTD	-8.22
Tr15y	-35.65%
Tr1m	17.93%
Tr1w	7.25%
Tr3m	-1.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 1.4M
Operating Income Growth3 Y	-13.82
Operating Income Growth5 Y	56.29
Operating margin	1.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	245,795,204%
Net Borrowing	1,378,272.8
Shares Insiders	24.27%
Shares Institutions	52.58%
Shares Out	340,079,684
Shares Qo Q	-1.15%
Shares Yo Y	0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -7M
Average Volume	453,990.6x
Bv Per Share	0.14
CAPEX	GBX -1.4M
Ch10y	-7.5
Ch15y	-38.33
Ch1m	17.93
Ch1w	7.25
Ch1y	2.07
Ch20y	-46.67
Ch3m	-1.82
Ch3y	-43.51
Ch5y	-84.32
Ch6m	-6.92
Change	3.86%
Change From Open	0.48
Close	14.25
Days Gap	3.37
Depreciation Amortization	1,601,261.1
Dollar Volume	1,616,278.4
Earnings Date	2026-05-15
EBIT	GBX 1.4M
EBITDA	GBX 3M
EPS	GBX -0.03
F Score	4
FCF	GBX -6.6M
FCF EV Yield	-16.59x
FCF Per Share	GBX -0.02
Financing CF	1,155,365
Fiscal Year End	December
Founded	1,992
Goodwill	2,243,819.3
Income Tax	GBX 4.6M
Investing CF	797,239
Is Primary Listing	1
Last Earnings Date	2025-11-18
Last Report Date	2025-12-31
Last Split Date	2000-07-03
Last Split Type	Forward
Ma150	15.74
Ma150ch	-5.98%
Ma20	13.97
Ma20ch	5.98%
Net CF	-2,257,977
Next Earnings Date	2026-05-15
Open	14.73
Position In Range	100
Ppne	7,250,052.4
Price Date	2026-05-08
Price EBITDA	GBX 16.79
Ptbv Ratio	1.29
Relative Volume	0.24x
Revenue	91,536,114x
SBC By Revenue	0.49x
Share Based Comp	451,744
Tax By Revenue	5.03x
Tr20y	-39.19%
Tr6m	-6.92%
Volume	109,208
Z Score	-1.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/BVC pay a dividend?

Capital-return profile for this ticker.

Performance

LON/BVC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/BVC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+52.6%

Share of float held by funds and institutions

Insider ownership

+24.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/BVC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.4

Neutral momentum band

Price vs 200-day MA

-6.5%

50/200-day relationship not available

Beta (5Y)

0.73

Less volatile than the market

Sharpe ratio

-0.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/BVC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/BVC stock rating?

lon/BVC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/BVC analysis?

The full report lives at /stocks/lon/BVC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/BVC?

The latest report frames lon/BVC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/BVC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.